Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil TherapyJan H. Beumer, Markus Joerger, Edward Chu et al.|Clinical Pharmacology & Therapeutics|2018Cited by 126
Improved Survival After Primary Tumor Surgery in Metastatic Breast CancerRené Warschkow, Markus Joerger, Beat Thuerlimann et al.|Annals of Surgery|2015Cited by 88
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trialMarkus Joerger, Andrés J.M. Ferreri, A. D. R. Huitema et al.|British Journal of Cancer|2010Cited by 85
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapyMarkus Joerger, Jan H.M. Schellens, Alwin D. R. Huitema et al.|Cancer Chemotherapy and Pharmacology|2015Cited by 55
The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of ActionMarkus Joerger, Martin Früh, Aurelius Omlin et al.|Current Drug Targets|2009Cited by 48